Zacks Investment Management X4 Pharmaceuticals, Inc Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.63 - $10.28 $357,774 - $554,739	-53,963 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.41 - $7.4 $10,646 - $14,563	-1,968 Reduced 3.52%	53,963 $347,000
Q3 2020 Nov 16, 2020	SELL	$6.09 - $9.15 $122,914 - $184,674	-20,183 Reduced 26.52%	55,931 $379,000
Q2 2020 Aug 14, 2020	BUY	$7.98 - $10.44 $607,389 - $794,630	76,114 New	76,114 $709,000

99.6M

421K

80.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $21.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.